CONTACT US
Share: Share on Facebook Share on Twitter Share on LinkedIn I recommend visiting cushmanwakefield.com to read:%0A%0A {0} %0A%0A {1}

Biomedical Sciences Continues Strong Growth in Singapore, Expected to Be Key Driver of Future Economy

Jayna Poh • 08/03/2022

Bolstered by increasing biotech investments and accelerating healthcare research, the biomedical sciences (BMS) industry has experienced strong growth in recent years, further reinforcing Singapore’s position as a leading biomedical science hub at the heart of Asia. According to Cushman & Wakefield’s latest report titled “Biomedical Sciences: A Niche Asset Class with Strong Growth Prospects”, BMS rents surged in the last two years, and the industry is looking to continue its growth trajectory in and beyond 2022.

“Given that innovation will be a key driver of the new economy, Singapore has continued to invest and nurture start-ups in the biotech sector which is rich in intellectual property and deep in technology. This is evidenced by the rapid growth of biotech start-ups over the past decade. In 2018, there were 100 home-grown biotech companies in Singapore, a 26.6% increase compared to 79 in 2017,” said Wong Xian Yang, Head of Research, Singapore at Cushman & Wakefield.

The rise in BMS demand and limited supply of quality BMS lab space has created a mismatch in demand and supply. The future supply of BMS lab space looks tight. Only two new major multi-user BMS developments will enter the market in the near term, namely Solaris @ Tai Seng (Estimated Completion: H2 2022) and Elementum (Estimated Completion: H2 2023). Over the longer term, new BMS supply will come from the redevelopment of 1 Science Park Drive, which is scheduled for completion in 2025.

Strong rental growth underpinned by robust demand and tight supply

Given tight occupancies and buoyant demand due to the pandemic, BMS rents at Biopolis and Science Park surged during 2020 and 2021. Biopolis can command higher rents and stronger rental growth compared to Science Park due to its newer infrastructure and the clustering of biomedical firms, creating a vibrant ecosystem for research and collaboration. 

“In 2021, BMS rents in Biopolis and Science Park increased by 5.7% and 3.5% yoy, respectively, to reach about S$6.13 and S$4.39 psf pm. This extended the rental growth of 5.5% and 3.5% yoy in the previous year for BMS spaces at Biopolis and Science Park, respectively,” said Brenda Ong, Executive Director, Logistics & Industrial at Cushman & Wakefield. “Going forward, rents of business park space for the BMS industry are expected to continue to trend upward by around 3.0% per annum, supported by healthy demand.”

Figure-Average-BMS-Lab

Other takeaways for biomedical sciences industry:  

The BMS industry will continue to reinforce its role as a key fourth pillar of the nation’s manufacturing economy. 

  • Significant increase in public sector funding to fuel growth: The Research, Innovation and Enterprise (RIE) 2025 Plan will channel S$25 billion into research and innovation. This represents a 32% increase compared to RIE2020, when the government committed S$19 billion – a testament to the government’s commitment to establish Singapore as a global research and development hub.
  • Potential conversion of industrial properties into BMS-ready developments: Continued growth in BMS rents would entice landlords or investors to convert parts or all existing developments into BMS-ready developments, accommodating the rising demand for BMS space. Investors or landlords looking to jump on the life science bandwagon via conversion of existing industrial spaces, would see more opportunities at Business Parks or B2 spaces. 
  • The growth of food tech driving up demand for space: With the city-state’s “30 by 30” goal of producing 30% of its nutritional needs locally by 2030, Singapore is transforming itself into the food tech hub of Asia given its land scarcity for intensive farming activities. MNCs and start-ups from around the world have set up their facilities here to take advantage of the emerging trends on the back of strong governmental support for the sector.
  • Prevailing megatrends to drive increased pharmaceutical spending over next decade: The growth of Asia’s pharmaceutical markets would be further boosted by prevailing mega trends, which includes an emerging middle class in Asia, increasing populations, ageing societies, and political pressure to expand healthcare services. These factors would lead to increases in drug purchases, driving pharmaceutical market growth. Though most of this growth will occur in the region’s large emerging markets, each country is expected to see a compound annual growth (CAGR) of 5-10% from 2018 to 2022. Singapore is poised to ride this wave of growth given its position as a biomedical hub in Asia Pacific.
  • Major biomedical clusters in Singapore continue to grow: There are currently a few biomedical clusters located across several parts of Singapore, with different regions catering to varying business needs of tenants in the BMS industry. Singapore’s western region is the main location for biomedical manufacturing and R&D activities. While the city centre area accommodates front office and business functions, developments at the city-fringe such as Science Park and Biopolis are where R&D operations are situated, and where business and HQ functions of biomedical companies are concentrated. 
  • Healthy demand for lab space: Demand for BMS space was already robust before the pandemic, evidenced by the strong demand for Biopolis and its consistently healthy occupancy rates in recent years. This demand remains strong into 2021, with Nucleos occupancy rates estimated to be around 98% at the end of the year. Space at Biopolis remains highly sought after with new BMS tenants such as ADM which opened their plant-based laboratory at Nucleos and A*STAR Infectious Diseases (ID) Labs at Immunos.
  • Current pipeline looks tight, but more asset conversions could be in the works: The sudden boom in demand seen for this segment and limited supply of quality BMS lab space has created a mismatch in demand and supply. Hence, the future supply of BMS lab space remains relatively limited. 


Click here to download Biomedical Sciences: A Niche Asset Class with Strong Growth Prospects.

Recent Press Releases

APAC DCIR - Card Image.png
Asia Pacific on track to overtake United States as the largest colocation data centre market before 2030

The Asia Pacific region is on track to overtake the United States as the largest colocation data centre market by both capacity and rental revenue before 2030, according to analysis from Cushman & Wakefield.

Amy Kathleen Kelly • 24/06/2025

global occupier report_CardImage.jpg
Downsizing eases as average lease sizes grow, according to global occupier report

More businesses are taking on larger leases as the era of downsizing slowly turns a corner, according to a report from global real estate services firm Cushman & Wakefield.

Amy Kathleen Kelly • 19/06/2025

APC Data Centre Construction per Capita_News Card Image.jpg
Malaysia, Thailand, Japan set pace on Asia Pacific data centre construction per capita through end of decade

Malaysia’s strong data centre development pipeline will see its population per megawatt ratio consolidate faster than any other Asia Pacific market between now and the end of the decade, with Thailand and Japan seeing the second and third fastest rates of consolidation, according to a new report from global real estate services firm Cushman & Wakefield.

Amy Kathleen Kelly • 12/06/2025

Sona Aggarwal as Managing Director_CrdImg.jpg
Cushman & Wakefield Appoints Sona Aggarwal as Managing Director, Head of Retail Sales and Strategy, Asia Pacific

Cushman & Wakefield, a leading global real estate services firm, is pleased to announce the appointment of Sona Aggarwal as Managing Director, Head of Retail Sales and Strategy, Asia Pacific.

Chek Yee Foo • 11/06/2025

skyscrapers.png
Cushman & Wakefield Strengthens its Leadership Team for Project & Development Services in Singapore and Southeast Asia

Cushman & Wakefield is pleased to announce a senior promotion and three new leadership appointments within its Project & Development Services (PDS) business across Singapore and Southeast Asia.

Chek Yee Foo • 22/04/2025

Matthew-Bouw.jpg
Cushman & Wakefield Names Matthew Bouw Chief Executive, APAC & EMEA

Cushman & Wakefield (NYSE: CWK) announced today the appointment of Matthew Bouw as Chief Executive, APAC & EMEA, effective from 1 May 2025. 

Richard Coleman • 16/04/2025

EMEA_ABSTRACT_AdobeStock_716595266.jpeg
Over US $100 billion needed to fund Asia Pacific data centre pipeline in the coming five to seven years:

APPROXIMATELY US $116 billion will be needed to build out the existing colocation data centre pipeline across Asia Pacific in the coming five to seven years.

Amy Kathleen Kelly • 27/02/2025

valuing-us-cre-environmental-performance-web-card
More pragmatic approach to esg needed to help building owners, investors, occupiers transition from brown to green

Cushman & Wakefield has launched a series of how-to guides to provide building owners and occupiers with practical, step-by-step advice on transitioning to greener buildings.

Amy Kathleen Kelly • 19/10/2023

With your permission we and our partners would like to use cookies in order to access and record information and process personal data, such as unique identifiers and standard information sent by a device to ensure our website performs as expected, to develop and improve our products, and for advertising and insight purposes.

Alternatively click on More Options and select your preferences before providing or refusing consent. Some processing of your personal data may not require your consent, but you have a right to object to such processing.

You can change your preferences at any time by returning to this site or clicking on Privacy & Cookies.
MORE OPTIONS
AGREE AND CLOSE
These cookies ensure that our website performs as expected,for example website traffic load is balanced across our servers to prevent our website from crashing during particularly high usage.
These cookies allow our website to remember choices you make (such as your user name, language or the region you are in) and provide enhanced features. These cookies do not gather any information about you that could be used for advertising or remember where you have been on the internet.
These cookies allow us to work with our marketing partners to understand which ads or links you have clicked on before arriving on our website or to help us make our advertising more relevant to you.
Agree All
Reject All
SAVE SETTINGS